Kana Hoshino

Title: Kana Hoshino: Innovator in Antibody Development

Introduction

Kana Hoshino is a prominent inventor based in Kobe, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 2 patents to her name, Hoshino is recognized for her innovative approaches to medical science.

Latest Patents

Hoshino's latest patents focus on the development of an anti-human Notch4 antibody. This invention provides an anti-human Notch4 antibody or a Notch4 binding fragment that may exhibit neutralizing activity against human Notch4. The pharmaceutical composition derived from this invention includes the antibody as the active ingredient. The inventors successfully obtained a mouse anti-human Notch4 antibody that demonstrates high neutralizing activity and binding affinity towards human Notch4. They also determined the complementarity determining region (CDR) sequence of the mouse anti-human Notch4 antibody, which facilitated the production of a humanized antibody comprising the variable region of heavy and light chains along with the CDR sequence.

Career Highlights

Kana Hoshino is currently employed at Eisai R&D Management Co., Ltd. Her work at this esteemed company has allowed her to focus on groundbreaking research in the field of antibody development. Hoshino's dedication to her work has positioned her as a key player in her area of expertise.

Collaborations

Throughout her career, Hoshino has collaborated with notable colleagues, including Yoshimasa Sakamoto and Kishan Agarwala. These collaborations have further enhanced her research and contributed to her success in the field.

Conclusion

Kana Hoshino is a remarkable inventor whose work in antibody development has the potential to impact medical science significantly. Her innovative patents and collaborations highlight her commitment to advancing biotechnology.